BIIB News and Press, Biogen Inc. From 06/09/24

FDA Accepts Eisai's Filing of LEQEMBI® (lecanemab-irmb) Supplemental Biologics License Application for IV Maintenance Dosing for the Treatment of Early Alzheimer's Disease PR Newswire TOKYO and CAMBRIDGE, Mass. , June 9, 2024 /PRNewswire/ -- Eisai C...

2024-06-08 14:00:00 ET More on Eli Lilly, Biogen Is It Possible Eli Lilly Is Breaking Out To New All-Time Highs? Biogen favored at RBC as Eli Lilly awaits FDA AdCom on Alzheimer’s drug FDA suggests safety warning for Eli Lilly Alzheimer’s drug ...

2024-06-07 15:00:58 ET More on the markets Going Into June, SPY Or VXF, Which Is The Better Buy? (Technical Analysis) SPY: 2 Options To Balance Out A Highly Concentrated Index Bitcoin's Fading Action Is A Huge Warning For Stock Market Liquidity Citi – ...

NEW YORK, NY / ACCESSWIRE / June 7, 2024 / Leading law firm Bleichmar Fonti & Auld LLP announces the upcoming July 22, 2024, deadline in the Biogen Inc. (Nasdaq:BIIB) Securities Class Action Lawsuit. If you invested in Biogen, you are encouraged to obtain additional information by visiting ...

Faruqi & Faruqi, LLP Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Losses Exceeding $100,000 In Biogen To Contact Him Directly To Discuss Their Options New York, New York--(Newsfile Corp. - June 7, 2024) - Faruqi & Faruqi, LLP, a leading national sec...

New York, New York--(Newsfile Corp. - June 6, 2024) - Leading law firm Bleichmar Fonti & Auld LLP announces the upcoming July 22, 2024, deadline in the Biogen Inc. (NASDAQ: BIIB) Securities Class Action Lawsuit. If you invested in Biogen, you are encouraged to obtain additional information by...

2024-06-06 10:09:40 ET More on Eli Lilly Is It Possible Eli Lilly Is Breaking Out To New All-Time Highs? Eli Lilly and Company (LLY) Lilly Oncology ASCO Investor Event (Transcript) Eli Lilly's Growth And Challenges: A Cautious Buy Eli Lilly snaps six straight...

NEW YORK, NY / ACCESSWIRE / June 6, 2024 / Leading law firm Bleichmar Fonti & Auld LLP announces the upcoming July 22, 2024, deadline in the Biogen Inc. (NASDAQ:BIIB) Securities Class Action Lawsuit. If you invested in Biogen, you are encouraged to obtain additional information by visiting ...

2024-06-06 07:09:15 ET More on Novartis, Roche, etc. Novartis AG (NVS) Investor Event at ASCO Conference Call (Transcript) Novartis: Buy This Blue-Chip Dividend Stock On Sale Now Roche Is Joining The Obesity Party But Questions Remain SA Asks: Which weight-lo...

2024-06-05 13:10:12 ET More on Biogen, Eli Lilly, etc. Eli Lilly and Company (LLY) Lilly Oncology ASCO Investor Event (Transcript) Eli Lilly's Growth And Challenges: A Cautious Buy Eli Lilly: Addressing Supply Challenges Should Accelerate Growth Alphabet taps...